Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Feb 24, 2015, before the open
10-K filed Feb 24, 2015, 55 days after period end · 0001047469-15-001081
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Revenue | $1.48M | $620.00K | $3.65M | $2.43M |
| EPS Diluted | -$0.36 | -$0.27 | -$0.27 | -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2014 · filed Feb 24, 2015 · 55 d after period end
+17.7% from the close of Feb 20, 2015 to the close of Feb 25, 2015, the first after the release.